111 (YI) EBITDA Margin Growth (5y) (2022 - 2025)
111 (YI) EBITDA Margin Growth (5y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 398.00 |
| Sep 30, 2025 | 493.00 |
| Jun 30, 2025 | 512.00 |
| Mar 31, 2025 | 650.00 |
| Dec 31, 2024 | -1,305.00 |
| Sep 30, 2024 | -971.00 |
| Jun 30, 2024 | -983.00 |
| Mar 31, 2024 | -2,163.00 |
| Dec 31, 2023 | -2,801.00 |
| Sep 30, 2023 | -2,388.00 |
| Jun 30, 2023 | 1,879.00 |
| Mar 31, 2023 | 1,033.00 |
| Dec 31, 2022 | 2,165.00 |
| Sep 30, 2022 | 2,553.00 |